Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read Pharma Industry News Is viral vector therapy finally gaining traction in chemotherapy-resistant pediatric tumors? Theriva’s APAO 2026 data shows viral–chemotherapy synergy in eye tumors. Find out what VCN-01 signals for pediatric oncology's biologics future. bySoujanya RaviFebruary 6, 2026